CLEVELAND – Funding for health care innovation remains robust, according to a panel of venture investors at the 2016 Medical Innovation Summit sponsored by Cleveland Clinic Innovations. Although they found plenty to like across biopharma and med-tech, investors nevertheless voiced caution about excessive costs built into a system that talks value-based reimbursement but continues to deliver care on a fee-for-service basis. Read More
